An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity

Arthritis&Rheumatology, EarlyView.

Source: Arthritis and Rheumatology - August 24, 2018 Category: Rheumatology Authors: An Tran ‐DuyPhD , Marjan Ghiti MoghadamMD , Martijn A. H. Oude VoshaarPhD , Harald E. VonkemanMD, PhD , Annelies BoonenMD, PhD , Philip ClarkePhD , Geoff McCollMD, PhD , Peter M. ten KloosterMD, PhD , T. R. ZijlstraMD, PhD , Willem F. Source Type: research